These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12062340)

  • 1. Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
    Nattel S
    Cardiovasc Res; 2002 May; 54(2):347-60. PubMed ID: 12062340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation.
    Nattel S
    Cardiovasc Res; 1999 May; 42(2):298-308. PubMed ID: 10533568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical remodeling in atrial fibrillation.
    Dobrev D
    Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.
    Courtemanche M; Ramirez RJ; Nattel S
    Cardiovasc Res; 1999 May; 42(2):477-89. PubMed ID: 10533583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.
    Shinagawa K; Derakhchan K; Nattel S
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):752-64. PubMed ID: 12698678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities : cause, consequence, or innocent bystander?
    Nattel S
    Circ Res; 1999 Sep; 85(5):473-6. PubMed ID: 10473677
    [No Abstract]   [Full Text] [Related]  

  • 8. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities.
    Nattel S; Dobrev D
    Eur Heart J; 2012 Aug; 33(15):1870-7. PubMed ID: 22507975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.
    Heijman J; Algalarrondo V; Voigt N; Melka J; Wehrens XH; Dobrev D; Nattel S
    Cardiovasc Res; 2016 Apr; 109(4):467-79. PubMed ID: 26705366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
    Aguilar M; Nattel S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ionic remodeling on cardiac antiarrhythmic drug actions.
    Nattel S
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):809-11. PubMed ID: 11707683
    [No Abstract]   [Full Text] [Related]  

  • 12. Atrial remodeling and novel pharmacological strategies for antiarrhythmic therapy in atrial fibrillation.
    Jost N; Kohajda Z; Kristóf A; Kovács PP; Husti Z; Juhász V; Kiss L; Varró A; Virág L; Baczkó I
    Curr Med Chem; 2011; 18(24):3675-94. PubMed ID: 21774760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.
    Nattel S; Heijman J; Zhou L; Dobrev D
    Circ Res; 2020 Jun; 127(1):51-72. PubMed ID: 32717172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biology of the substrate of atrial fibrillation].
    Hatem S
    Biol Aujourdhui; 2012; 206(1):5-9. PubMed ID: 22463991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balance between sodium and calcium currents underlying chronic atrial fibrillation termination: An in silico intersubject variability study.
    Liberos A; Bueno-Orovio A; Rodrigo M; Ravens U; Hernandez-Romero I; Fernandez-Aviles F; Guillem MS; Rodriguez B; Climent AM
    Heart Rhythm; 2016 Dec; 13(12):2358-2365. PubMed ID: 27569443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation pathophysiology: implications for management.
    Iwasaki YK; Nishida K; Kato T; Nattel S
    Circulation; 2011 Nov; 124(20):2264-74. PubMed ID: 22083148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
    Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
    Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.
    Dobrev D; Nattel S
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):293-9. PubMed ID: 18791467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic targets for atrial fibrillation.
    Bhakta D; Miller JM
    Expert Opin Ther Targets; 2007 Sep; 11(9):1161-78. PubMed ID: 17845143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation.
    Nattel S; Li D
    Circ Res; 2000 Sep; 87(6):440-7. PubMed ID: 10988234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.